DIVISION OF DRUGS, DEVICES AND COSMETICS
The Division of Drugs, Devices and Cosmetics safeguards the health, safety, and welfare of the citizens of the state of Florida from injury due to the use of adulterated, contaminated, misbranded drugs, drug ingredients and cosmetics by administering the provisions of the Florida Drug and Cosmetic Act (Chapter 499, F.S.). The Program carries out its responsibilities through three bureaus: Compliance & Enforcement, Licensing and Legal.
Information on Meningitis Outbreak
The Department of Health and DBPR strongly advise all Florida health care facilities and practitioners to immediately discontinue using any products from the New England Compounding Center. Click here for more information.
The CDDP was created during the 2006 Legislative Session with the passage of House Bill 371, which was sponsored by Representative Gayle Harrell. The purpose of the CDDP is to provide access to the drugs and supplies used to treat cancer to patients who are uninsured and do not qualify for Medicare, third-party insurance or any other state or federal programs. Section 499.029, F.S., authorizes the donation of cancer drugs and supplies by any person or entity to a participant facility for re-dispensing to an eligible recipient.
Effective July 1, 2011, in accordance with Section 499.0121(14), Florida Statutes, certain controlled substance distributors must submit monthly distribution reports to the department. The affected companies distribute controlled substances (Schedules II-V, inclusive) in or into Florida. To find out whether your company must report and for more information click here.
DRUG WHOLESALE DISTRIBUTOR ADVISORY COUNCIL
The Drug Wholesale Distributor Advisory Council is comprised of 11 members representing various aspects of the industry. See 499.01211, F.S., for the specific qualifications to serve on the council. The Council's role is to review Chapter 499, Part I, and the rules, provide input to the department regarding all proposed rules, make recommendations to the department to improve the protection of the prescription drugs and public health, make recommendations to improve coordination with other states' regulatory agencies and the federal government concerning the wholesale distribution of drugs, and make recommendations to minimize the impact of regulation of the wholesale distribution industry while ensuring protection of the public health.
To sign up for email alerts or notifications, please visit http://www.myfloridalicense.com/dbpr/ddc/subscribe_alertsystem.html.